Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study NOVA to Evaluate Guselkumab in Hidradenitis Suppurativa news with additional features

$
0
0
DGAPNews MorphoSys AG Key words Study19.11.2018 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany November 19 2018 MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study NOVA to Evaluate Guselkum...

Viewing all articles
Browse latest Browse all 2985

Trending Articles